CLINICAL AND ENDOSCOPIC OUTCOMES WITH USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE LONG-TERM EXTENSION PERIOD OF THE STARDUST TRIAL
Autores da FMUP
Participantes de fora da FMUP
- Peyrin-Biroulet, Laurent
- Vermeire, Severine
- D'Haens, Geert R.
- Panes, Julian
- Dignass, Axel
- Nazar, Maciej
- Le Bars, Manuela
- Lahaye, Marjolein
- Ni, Lioudmila
- Bravata, Ivana
- Lavie, Frederic
- Daperno, Marco
- Lukas, Milan
- Armuzzi, Alessandro
- Lowenberg, Mark
- Gaya, Daniel R.
- Danese, Silvio
Unidades de investigação
Abstract
Abstract no disponible
Filiações
Filiações não disponíveis
Projetos associados
Gut microbiome and IBD therapy: an interplay?
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (GutIBD) . 2021
Iron deficiency and inflammatory bowel disease. Correlation with inflammation and Vitamin D status.
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (IronIBD) . 2021
Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients.
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (4WARD) . 2021
Isolated Ulceration of Crohn’s Anastomosis
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2021
Therapeutic Drug Monitoring: An Emergent Approach in Inflammatory Bowel Disease
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2021
Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2019
